amdinocillin has been researched along with cefazolin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Bischof-Léger, E; Helm, EB; Stille, W | 1 |
| Gibson, G; Nachamkin, I; Samel, C; Sawyer, K; Skalina, D | 1 |
| Barry, AL; Beskid, G; Cleeland, R; Fallat, V; Isenberg, HD; Murray, PR; Pierson, C; Squires, E; Tilton, RC | 1 |
| Coppens, L; Klastersky, J; Menday, AP; Meunier-Carpentier, F | 1 |
| Borowski, J; Zaremba, M; Zukowska-Nytko, K | 1 |
1 trial(s) available for amdinocillin and cefazolin
| Article | Year |
|---|---|
Carbenicillin plus cefazolin with or without mecillinam as an early treatment of bacteremia caused by gram-negative organisms: randomized double-blind study.
Topics: Amdinocillin; Carbenicillin; Cefazolin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Penicillanic Acid; Random Allocation; Sepsis | 1980 |
7 other study(ies) available for amdinocillin and cefazolin
| Article | Year |
|---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
[Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Topics: Amdinocillin; Ampicillin; Cefazolin; Cross Reactions; Drug Synergism; Escherichia coli; Kinetics; Klebsiella; Penicillanic Acid; Proteus | 1978 |
In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
Topics: Amdinocillin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Piperacillin; Ticarcillin | 1988 |
Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin; Ticarcillin | 1987 |
[Studies on the combined effect of 6/N,N-hexyleneformamidine/-penicillanic acid (Preparation HX) and selected beta-lactam antibiotics on Escherichia coli and Salmonella. II. Studies in vivo].
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cephradine; Drug Synergism; Escherichia coli Infections; Mice; Mice, Inbred BALB C; Penicillanic Acid; Salmonella Infections | 1982 |